Validating the EQ-5D with Time Trade off for the German Population
Greiner, W., Claes, C., Busschbach, J. J. V., von der Schulenburg, J.-M. Graf
Published in The European journal of health economics (01.06.2005)
Published in The European journal of health economics (01.06.2005)
Get full text
Journal Article
Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?
Linder, Roland, Zeidler, J., Verheyen, F., von der Schulenburg, J.-M. Graf, Haverich, A., Schilling, T.
Published in The European journal of health economics (01.07.2018)
Published in The European journal of health economics (01.07.2018)
Get full text
Journal Article
Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany
Aumann, I., Treskova, M., Hagemann, N., von der Schulenburg, J.-M.
Published in Applied health economics and health policy (01.08.2016)
Published in Applied health economics and health policy (01.08.2016)
Get full text
Journal Article
Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective
Mittendorf, T., Dietz, B., Sterz, R., Cifaldi, M. A., Kupper, H., von der Schulenburg, J.-M.
Published in Rheumatology (Oxford, England) (01.02.2008)
Published in Rheumatology (Oxford, England) (01.02.2008)
Get full text
Journal Article
Direct costs related to rheumatoid arthritis: the patient perspective
Hülsemann, J L, Mittendorf, T, Merkesdal, S, Zeh, S, Handelmann, S, von der Schulenburg, J‐ M, Zeidler, H, Ruof, J
Published in Annals of the rheumatic diseases (01.10.2005)
Published in Annals of the rheumatic diseases (01.10.2005)
Get full text
Journal Article
Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany
Wahler, S, Müller, A, Koll, C, Seyed-Abbaszadeh, P, Von Der Schulenburg, JM
Published in Journal of market access & health policy (2021)
Published in Journal of market access & health policy (2021)
Get full text
Journal Article
Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country
Mennini, F. S., Marcellusi, Andrea, von der Schulenburg, J. M. Graf, Gray, A., Levy, P., Sciattella, P., Soro, M., Staffiero, G., Zeidler, J., Maggioni, A., Schmieder, R. E.
Published in The European journal of health economics (01.11.2015)
Published in The European journal of health economics (01.11.2015)
Get full text
Journal Article
A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer
Lange, A, Prenzler, A, Frank, M, Kirstein, M, Vogel, A, von der Schulenburg, J.M
Published in European journal of cancer (1990) (01.01.2014)
Published in European journal of cancer (1990) (01.01.2014)
Get full text
Journal Article
Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer’s data sources
Ruof, J, Hülsemann, J L, Mittendorf, T, Handelmann, S, von der Schulenburg, J M, Zeidler, H, Merkesdal, S
Published in Annals of the rheumatic diseases (01.06.2003)
Published in Annals of the rheumatic diseases (01.06.2003)
Get full text
Journal Article
Cost of poor adherence to anti-hypertensive therapy in five European countries
Mennini, F. S., Marcellusi, A., von der Schulenburg, J. M. Graf, Gray, A., Levy, P., Sciattella, P., Soro, M., Staffiero, G., Zeidler, J., Maggioni, A., Schmieder, R. E.
Published in The European journal of health economics (01.01.2015)
Published in The European journal of health economics (01.01.2015)
Get full text
Journal Article
The Fourth Hurdle as Controlling Instrument for Expenditure on Medication?
Kulp, W., Greiner, W., J.-M. von der Schulenburg
Published in The European journal of health economics (01.03.2003)
Published in The European journal of health economics (01.03.2003)
Get full text
Journal Article
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe
Kuhlmann, A., Schmidt, T., Treskova, M., López-Bastida, J., Linertová, R., Oliva-Moreno, J., Serrano-Aguilar, P., Posada-de-la-Paz, M., Kanavos, P., Taruscio, D., Schieppati, A., Iskrov, G., Péntek, M., Delgado, C., von der Schulenburg, J. M., Persson, U., Chevreul, K., Fattore, G.
Published in The European journal of health economics (01.04.2016)
Published in The European journal of health economics (01.04.2016)
Get full text
Journal Article
Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review
Aumann, I, Rozanski, K, Damm, K, Graf von der Schulenburg, J-M
Published in Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) (01.10.2016)
Published in Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) (01.10.2016)
Get more information
Journal Article
Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan
Frank, M, Eidt-Koch, D, Aumann, I, Reimann, A, Wagner, T O F, Graf von der Schulenburg, J-M
Published in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz (01.10.2014)
Published in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz (01.10.2014)
Get full text
Journal Article
Impact of guideline adherence on mortality in treatment of left heart failure
Neubauer, S, Schilling, T, Zeidler, J, Lange, A, Engel, S, Linder, R, Verheyen, F, von der Schulenburg, J-M Graf, Haverich, A
Published in Herz (01.11.2016)
Published in Herz (01.11.2016)
Get full text
Journal Article